Growth Metrics

Sarepta Therapeutics (SRPT) Enterprise Value Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -31.04%
Dec 31, 2025 37.04%
Sep 30, 2025 46.39%
Jun 30, 2025 45.21%
Mar 31, 2025 62.41%
Dec 31, 2024 19.18%
Sep 30, 2024 30.87%
Jun 30, 2024 21.51%
Mar 31, 2024 26.10%
Dec 31, 2023 15.74%
Sep 30, 2023 16.35%
Jun 30, 2023 3.49%
Mar 31, 2023 6.52%
Dec 31, 2022 5.98%
Sep 30, 2022 -29.60%
Jun 30, 2022 -11.62%
Mar 31, 2022 -15.86%
Dec 31, 2021 -9.15%
Sep 30, 2021 11.95%
Jun 30, 2021 16.20%
Mar 31, 2021 19.96%
Dec 31, 2020 -72.36%
Sep 30, 2020 -73.14%
Jun 30, 2020 -86.87%
Mar 31, 2020 -61.52%
Dec 31, 2019 4.19%
Sep 30, 2019 -32.30%
Jun 30, 2019 -16.22%
Mar 31, 2019 -28.14%
Dec 31, 2018 -8.79%
Sep 30, 2018 -28.37%
Jun 30, 2018 -215.39%
Mar 31, 2018 -168.76%
Dec 31, 2017 -239.49%
Sep 30, 2017 -49.94%
Jun 30, 2017 -408.04%
Mar 31, 2017 -154.22%
Dec 31, 2016 -249.28%
Sep 30, 2016 -312.30%
Jun 30, 2016 33.51%
Mar 31, 2016 -61.45%
Dec 31, 2015 56.74%
Sep 30, 2015 -77.46%
Jun 30, 2015 16.55%
Mar 31, 2015 57.77%
Dec 31, 2014 20.39%
Sep 30, 2014 79.96%
Jun 30, 2014 34.68%
Mar 31, 2014 -34.11%
Dec 31, 2013 -40.79%
Sep 30, 2013 -639.45%
Jun 30, 2013 -567.33%
Mar 31, 2013 -449.24%
Dec 31, 2012 -370.28%
Sep 30, 2012 18.05%
Jun 30, 2012 54.80%
Mar 31, 2012 -31.31%
Dec 31, 2011 -18.80%
Sep 30, 2011 -28.88%
Jun 30, 2011 -47.48%